HPTN Publications

Landovitz RJ, Delany-Moretlwe S, Fogel JM, Marzinke MA, Piwowar-Manning E, Richardson P, Halvas EK, Mellors JW, Persaud D, Kofron R, McCauley M, Rose S, Rinehart AR, Rooney JF, Adeyeye A, Cohen MS, Donnell D, Hosseinipour MC, Grinsztejn B, Eshleman SH; HP . Features of HIV Infection in the Context of Long-Acting Cabotegravir Preexposure Prophylaxis. N Engl J Med.

Landovitz RJ, Hanscom BS, Clement ME, Tran HV, Kallas EG, Magnus M, Sued O, Sanchez J, Scott H, Eron JJ, Del Rio C, Fields SD, Marzinke MA, Eshleman SH, Donnell D, Spinelli MA, Kofron RM, Berman R, Piwowar-Manning EM, Richardson PA, Sullivan PA, Lucas JP, . Efficacy & safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men & transgender women who have sex with men 1 year after study unblinding. Lancet HIV. 2023, 10: e767-e778

Landovitz RJ, Li S, Grinsztejn B, Dawood H, Liu AY, Magnus M, Hosseinipour MC, Panchia R, Cottle L, Chau G, Richardson P, Marzinke MA, Hendrix CW, Eshleman SH, Zhang Y, Tolley E, Sugarman J, Kofron R, Adeyeye A, Burns D, Rinehart AR, Margolis D, Spreen WR, Cohen MS, McCauley M, Eron JJ . Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial. PLoS Med. 2018, 15: e1002690

Landovitz RJ, Zangeneh SZ, Chau G, Grinsztejn B, Eron JJ, Dawood H, Liu AY, Panchia R, Hosseinipour MC, Kofron R, Margolis DA, Rinehart A, Adeyeye A, Burns D, McCauley M, Cohen MS, Currier JS . Cabotegravir is Not Associated with Weight Gain in HIV-uninfected Individuals in HPTN 077. Clin Infect Dis. 2019

Lao-Tzu Allan-Blitz, Timothy W Menza, Vanessa Cummings, Charlotte A Gaydos, Leo Wilton, Kenneth H Mayer . Differing Correlates of Incident Bacterial Sexually Transmitted Infections Among a Cohort of Black Cisgender Men Who Have Sex With Men and Transgender Women Recruited in 6 US Cities (HIV Prevention Trials Network 061). Sexually Transmitted Diseases. 2022, 49: e79-e84

Latkin C1, Donnell D, Liu TY, Davey-Rothwell M, Celentano D, Metzger D, Latkin C . The dynamic relationship between social norms and behaviors: the results of an HIV prevention network intervention for injection drug users. Addiction. 2013, 108: 934-43

Latkin CA, Van Tieu H, Fields S, Hanscom BS, Connor M, Hanscom B, Hussen SA, Scott HM, Mimiaga MJ, Wilton L, Magnus M, Chen I, Koblin BA . Social Network Factors as Correlates and Predictors of High Depressive Symptoms Among Black Men Who Have Sex with Men in HPTN 061. AIDS Behav. 2017, 21: 1163-1170

Lawrence Corey, M.D., Peter B. Gilbert, Ph.D., Michal Juraska, Ph.D., David C. Montefiori, Ph.D., Lynn Morris, Ph.D., Shelly T. Karuna, M.D., Srilatha Edupuganti, M.D., Nyaradzo M. Mgodi, M.B., Ch.B., M.Med., Allan C. deCamp, Ph.D., Erika Rudnicki, M.S., . Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition. N Engl J Med. 2021, 384: 1003-1014